315717-76-1 Usage
Uses
Used in Organic Synthesis:
3-Aminomethyl-1-N-Cbz-piperidine is utilized as a building block in organic synthesis for the preparation of a variety of pharmaceuticals and biologically active molecules. Its structural features make it a valuable component in the creation of complex organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-Aminomethyl-1-N-Cbz-piperidine is used as a reagent in the synthesis of peptide-based drugs. Its presence in these drugs can contribute to their therapeutic effects, making it an essential component in drug development processes.
Used in Enzyme and Receptor Inhibition Research:
3-Aminomethyl-1-N-Cbz-piperidine has been studied for its pharmacological properties, including its potential as an inhibitor of certain enzymes and receptors. This research is crucial for understanding the compound's interactions with biological systems and its possible use in the treatment of various diseases.
Overall, 3-Aminomethyl-1-N-Cbz-piperidine holds a significant position in the chemical and pharmaceutical industries due to its diverse applications and potential for further development in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 315717-76-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,5,7,1 and 7 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 315717-76:
(8*3)+(7*1)+(6*5)+(5*7)+(4*1)+(3*7)+(2*7)+(1*6)=141
141 % 10 = 1
So 315717-76-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O2/c15-9-13-7-4-8-16(10-13)14(17)18-11-12-5-2-1-3-6-12/h1-3,5-6,13H,4,7-11,15H2
315717-76-1Relevant academic research and scientific papers
Disubstituted pyrimidines as Lck inhibitors
Hunt, Julianne A.,Beresis, Richard T.,Goulet, Joung L.,Holmes, Mark A.,Hong, Xinfang J.,Kovacs, Ernest,Mills, Sander G.,Ruzek, Rowena D.,Wong, Frederick,Hermes, Jeffrey D.,Park, Young-Whan,Salowe, Scott P.,Sonatore, Lisa M.,Wu, Lin,Woods, Andrea,Zaller, Dennis M.,Sinclair, Peter J.
supporting information; scheme or table, p. 5440 - 5443 (2010/04/26)
We have developed a family of 4-benzimidazolyl-N-piperazinethyl-pyrimidin-2-amines that are subnanomolar inhibitors of Lck. A subset of these Lck inhibitors, with heterocyclic substituents at the benzimidazole C5, are also low-nanomolar inhibitors of cell
NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTIVITY
-
Page/Page column 17-18, (2010/02/06)
The invention relates to novel antibacterial compounds of formula (I).
SRC kinase inhibitor compounds
-
, (2008/06/13)
Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of proteins tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis and psoriasis.
